Delivery Order SPE2DR25D2006-SPE2DR26F57NF
- Not listed
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,295.32 for Mucinex D ER 600-60 mg tablets (18-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,858.06 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18 count) with a completion date of June 2, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's corporate headquarters location....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,114.67 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Mucinex D ER 600-60 mg tablets in 18-count packages. This firm fixed-price delivery order is scheduled for completion by January 15, 2026, and represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,294.55 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 15, 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate headquarters. AmerisourceBergen Drug Corp operates...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,713.98 to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 1,200-120 mg tablets (24-count packaging), with an ultimate completion date of January 20, 2026. This is a firm fixed-price, non-set-aside contract with performance to be fulfilled in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for Mucinex D ER 600-60 mg tablets (36-count) at a fixed price of $1,194.52, with completion scheduled for January 13, 2026. This non-set-aside, competitively awarded contract represents a task order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,491.32 to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18 count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $1,795.30 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count). This firm fixed-price contract, awarded on August 26, 2025, with completion targeted for August 27, 2025, represents a small-value pharmaceutical supply transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $2,196.95 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside contract utilizes firm fixed-price pricing and represents a small-value pharmaceutical procurement from the awardee's corporate office located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,667.26. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57NFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,702.92 to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18 count). This firm fixed-price contract, awarded on January 21, 2026, with an ultimate completion date of January 22, 2026, represents a small-value pharmaceutical procurement executed through the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems including the Department of Defense, Defense Health Agency, and U.S. Coast Guard. The company holds a significant single-award indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which enables the supply of a comprehensive range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs globally. This delivery order for Mucinex D represents a routine task order issued under that broader pharmaceutical supply vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/20/26 |